共 14 条
[1]
Emerging role of glutamate in the pathophy-siology and treatment of schizophrenia. Goff DC,Coyle JT. American Journal of Psychiatry . 2001
[2]
Amelioration of negative symptoms in schizophrenia by glycine. Javitt DC,Zylberman I,Zukin SR,et al. American Journal of Psychiatry . 1994
[3]
Low cerebrospinal fluidglutamate in schizophrenic patients and a new hypothesis onschizophrenia. Kim JS,Kornhuber HH,Schmid BW,et al. Neuroscience Letters . 1980
[4]
Glutamate receptor expression inschizophrenic brain. Meador-woodrutf JH,Healy DJ. Brain Research Reviews . 2000
[5]
Molecular aspects of glutamate dysregula- tion:implications for schizophrenia and its treataieot. Christine K,Stephan H. Pharmacology and Therapeutics . 2003
[6]
Regulation of NMDA Receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs. Riva MA,Tascedda F,Lovati E,et al. Molecular Brain Research . 1997
[7]
Abnormal excitatoryneurotransmitter metabolism in schizophrenic brains. Tsai G,Passani LA,Slusher BS,et al. Archives of General Psychiatry . 1995
[8]
D-cycloserine added to risperidone in patients with primary negative symptoms in schizo-phrenia. Evins AE,Amico ED,Posever TA,et al. Schizophrenia Research . 2002
[9]
Regulation of ionotropicglutamate receptors in the rat brain in response to the atypicalantipsychotic seroquel (quetiapine fumarate). Tascedda F,lovati E,Blom JMC,et al. Neuropsychopharmacology . 1999
[10]
Modulation of glutamatereceptors in response to the novel antipsychotic olanzapine inrats. Fabio T,John MC,Blom NB,et al. Biological Psychiatry . 2001